ADC Therapeutics SA (NYSE:ADCT) Given Consensus Rating of “Hold” by Analysts

Shares of ADC Therapeutics SA (NYSE:ADCT – Get Free Report) have received a consensus rating of “Hold” from the six analysts that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Begins Coverage on LiqTech International (NASDAQ:LIQT)
Next post Analysts Set Old National Bancorp (NASDAQ:ONB) Target Price at $16.92